1. 2.3.

Ann Arbor Spark

Webinar: Using Genomics to Accelerate Drug Development for Neurodegenerative Diseases

Thursday, March 26 2020 at 11:00am

Drug targets with human genetic evidence of disease association are twice as likely to lead to approval (King et al. 2019). But navigating the millions of genetic data points to comprehensively identify genomic drivers of a target indication or drug pathway is daunting.

Understanding the molecular drivers of disease accelerates drug development at each stage of the process. It…

There is a proven process to assemble essential genomic insight into Neurodegenerative and other rare and inherited diseases to drive better target selection and biomarker identification.

In this webinar, Genomenon Founder & CSO, Dr. Mark Kiel, MD, PhD will use real-world examples to demonstrate how a Comprehensive Genomic Landscape for a disease, pathway or gene set has empowered Pharmaceutical researchers and translational teams to understand genetic and rare diseases at the molecular level.

You will learn: